Brain, Vol. 124, No. 11, 2203-2214,
November 2001
© 2001 Oxford University Press
T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases
1 CNS Inflammation Group, School of Biological Sciences, University of Southampton and 2 2MRC Biochemical and Clinical Magnetic Resonance Unit, Department of Biochemistry, University of Oxford, UK
Correspondence to:
Dr T. A. Newman, CNS Inflammation Group, School of Biological Sciences, University of Southampton, Biomedical Sciences Building, Southampton SO16 7PX, UK E-mail: tan{at}soton.ac.uk
Recent evidence has highlighted the fact that axon injury is an important component of multiple sclerosis pathology. The issue of whether a CNS antigen-specific immune response is required to produce axon injury remains unresolved. We investigated the extent and time course of axon injury in a rodent model of a delayed-type hypersensitivity (DTH) reaction directed against the mycobacterium bacille Calmette-Guérin (BCG). Using MRI, we determined whether the ongoing axon injury is restricted to the period during which the blood–brain barrier is compromised. DTH lesions were initiated in adult rats by intracerebral injection of heat-killed BCG followed by a peripheral challenge with BCG. Our findings demonstrate that a DTH reaction to a non-CNS antigen within a CNS white matter tract leads to axon injury. Ongoing axon injury persisted throughout the 3-month period studied and was not restricted to the period of blood–brain barrier breakdown, as detected by MRI enhancing lesions. We have previously demonstrated that matrix metalloproteinases (MMPs) are upregulated in multiple sclerosis plaques and DTH lesions. In this study we demonstrated that microinjection of activated MMPs into the cortical white matter results in axon injury. Our results show that axon injury, possibly mediated by MMPs, is immunologically non-specific and may continue behind an intact blood–brain barrier.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y Benesova, A Vasku, H Novotna, J Litzman, P Stourac, M Beranek, Z Kadanka, and J Bednarik Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis Multiple Sclerosis, March 1, 2009; 15(3): 316 - 322. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Xue, Y. Fan, S. Liu, D. A. Zygun, A. Demchuk, and V. W. Yong Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage Brain, January 1, 2009; 132(1): 26 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Galvan, S. Luchetti, A. M. Burgos, H. X. Nguyen, M. J. Hooshmand, F. P. T. Hamers, and A. J. Anderson Deficiency in Complement C1q Improves Histological and Functional Locomotor Outcome after Spinal Cord Injury J. Neurosci., December 17, 2008; 28(51): 13876 - 13888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Minagar, J. S. Alexander, R. N. Schwendimann, R. E. Kelley, E. Gonzalez-Toledo, J. J. Jimenez, L. Mauro, W. Jy, and S. J. Smith Combination Therapy With Interferon Beta-1a and Doxycycline in Multiple Sclerosis: An Open-Label Trial Arch Neurol, February 1, 2008; 65(2): 199 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. W. Yong, F. Giuliani, M. Xue, A. Bar-Or, and L. M. Metz Experimental models of neuroprotection relevant to multiple sclerosis Neurology, May 29, 2007; 68(22_suppl_3): S32 - S37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Liu and P. J. Hornsby Senescent Human Fibroblasts Increase the Early Growth of Xenograft Tumors via Matrix Metalloproteinase Secretion Cancer Res., April 1, 2007; 67(7): 3117 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Harris, R. K. Nuttall, P. T. Elkington, J. A. Green, D. E. Horncastle, M. B. Graeber, D. R. Edwards, and J. S. Friedland Monocyte-Astrocyte Networks Regulate Matrix Metalloproteinase Gene Expression and Secretion in Central Nervous System Tuberculosis In Vitro and In Vivo J. Immunol., January 15, 2007; 178(2): 1199 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Sastre-Garriga, M Comabella, L Brieva, A Rovira, M Tintore, and X Montalban Decreased MMP-9 production in primary progressive multiple sclerosis patients Multiple Sclerosis, August 1, 2004; 10(4): 376 - 380. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Kerschensteiner, C. Stadelmann, B. S. Buddeberg, D. Merkler, F. M. Bareyre, D. C. Anthony, C. Linington, W. Bruck, and M. E. Schwab Targeting Experimental Autoimmune Encephalomyelitis Lesions to a Predetermined Axonal Tract System Allows for Refined Behavioral Testing in an Animal Model of Multiple Sclerosis Am. J. Pathol., April 1, 2004; 164(4): 1455 - 1469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nitsch, E. E. Pohl, A. Smorodchenko, C. Infante-Duarte, O. Aktas, and F. Zipp Direct Impact of T Cells on Neurons Revealed by Two-Photon Microscopy in Living Brain Tissue J. Neurosci., March 10, 2004; 24(10): 2458 - 2464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Larsen, J. E. Wells, W. B. Stallcup, G. Opdenakker, and V. W. Yong Matrix Metalloproteinase-9 Facilitates Remyelination in Part by Processing the Inhibitory NG2 Proteoglycan J. Neurosci., December 3, 2003; 23(35): 11127 - 11135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bar-Or, R. K. Nuttall, M. Duddy, A. Alter, H. J. Kim, I. Ifergan, C. J. Pennington, P. Bourgoin, D. R. Edwards, and V. W. Yong Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis Brain, December 1, 2003; 126(12): 2738 - 2749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Giuliani, C. G. Goodyer, J. P. Antel, and V. W. Yong Vulnerability of Human Neurons to T Cell-Mediated Cytotoxicity J. Immunol., July 1, 2003; 171(1): 368 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F Lythgoe, N. R Sibson, and N. G Harris Neuroimaging of animal models of brain disease Br. Med. Bull., March 1, 2003; 65(1): 235 - 257. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. Medana and M. M. Esiri Axonal damage: a key predictor of outcome in human CNS diseases Brain, March 1, 2003; 126(3): 515 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Waubant, D. Goodkin, A. Bostrom, P. Bacchetti, J. Hietpas, R. Lindberg, and D. Leppert IFN{beta} lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS Neurology, January 14, 2003; 60(1): 52 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Rosenberg Matrix Metalloproteinases and Neuroinflammation in Multiple Sclerosis Neuroscientist, December 1, 2002; 8(6): 586 - 595. [Abstract] [PDF]
|
|
|
|
|
|
D M Chari and W F Blakemore New insights into remyelination failure in multiple sclerosis: implications for glial cell transplantation Multiple Sclerosis, August 1, 2002; 8(4): 271 - 277. [Abstract] [PDF]
|
|
|
|
|
|
F. Castelli, C. Frith, F. Happe, and U. Frith Autism, Asperger syndrome and brain mechanisms for the attribution of mental states to animated shapes Brain, August 1, 2002; 125(8): 1839 - 1849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Brundula, N. B. Rewcastle, L. M. Metz, C. C. Bernard, and V. W. Yong Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis Brain, June 1, 2002; 125(6): 1297 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Buljevac, H. Z. Flach, W. C. J. Hop, D. Hijdra, J. D. Laman, H. F. J. Savelkoul, F. G. A. van der Meche, P. A. van Doorn, and R. Q. Hintzen Prospective study on the relationship between infections and multiple sclerosis exacerbations Brain, May 1, 2002; 125(5): 952 - 960. [Abstract] [Full Text] [PDF]
|
|